[Development of new vaccination strategies against tuberculosis].
Tuberculosis still represents a major global health problem. Despite the possibility of chemotherapeutic treatment, effective control of the disease could best be achieved by the adjunct of active vaccination procedures. BCG-vaccination, unfortunately proved less effective in developing countries than originally thought. Therefore, the development of a new generation of tuberculosis vaccines should be considered. Recent achievements in biotechnology have laid the basis for such a development. In this article the major steps towards a new tuberculosis vaccine will be discussed briefly.
D000917:Antibody Formation; D000941:Antigens / Q000276:immunology*; D001500:BCG Vaccine / Q000276:immunology*; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000276:immunology; D014397:Tuberculosis, Pulmonary / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology*
D000941:Antigens; D001500:BCG Vaccine; D014614:Vaccines, Synthetic
Entwicklung neuer Impfstrategien gegen Tuberkulose.